📰 Looking Statement News
Page 45 - Looking Statement News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Looking Statement. Real-time updates on events, politics, business and more.
January 17, 2023
TORONTO, ON / ACCESSWIRE / January 17, 2023 / Big Tree Carbon Inc. (the "Company" or "Big Tree") (TSXV:BIGT) is pleased to announce that Ian Brodie-Brown, Director of Business Development, will speak on
January 17, 2023
Technip Energies (PARIS: TE) as leader of a joint venture composed of Samsung Engineering and Tecnimont S.p.A. (TST JV) has been awarded a Pre-Construction Services Agreement (PCSA) related to the Onshore
January 17, 2023
(2023-01-17 | TSXV:BIGT) Big Tree to Speak at 2nd Energy Transition for Metals and Mining Summit
January 13, 2023
RAHWAY, NJ / ACCESSWIRE / January 13, 2023 / Merck (NYSE:MRK), known as MSD outside of the United States and Canada, was named one of America's Most JUST Companies, making this the sixth consecutive year
January 12, 2023
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of common stock of Imago BioSciences, Inc. (Nasdaq: IMGO), at a purchase price of $36.00 per share in cash, without ...
January 10, 2023
TechnipFMC (NYSE: FTI) has been awarded a significant(1) engineering, procurement, construction, and installation contract by Wintershall Dea Norge AS for its Dvalin North project. The contract covers
January 10, 2023
/PRNewswire/ -- MDU Resources Group, Inc. (NYSE: MDU) announced today that Nathan W. Ring has been named chief financial officer of the companys wholly owned...
January 10, 2023
/PRNewswire/ -- MDU Resources Group, Inc. (NYSE: MDU) announced today that Nathan W. Ring has been named chief financial officer of the companys wholly owned...
December 27, 2022
/PRNewswire/ -- EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery systems (DDS), announced today that it...
December 21, 2022
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe AstraZeneca and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced